Used in the synthesis of Janus kinase (JAK) inhibitors, particularly for the development of pharmaceuticals targeting inflammatory and autoimmune diseases such as rheumatoid arthritis and psoriasis. Its chiral structure enables selective interaction with kinase enzymes, improving drug efficacy and reducing off-target effects. Commonly employed in late-stage functionalization during medicinal chemistry optimization to enhance metabolic stability and bioavailability of drug candidates.